Results out today confirm that the drug donanemab, hailed as a turning point in the fight against Alzheimer’s, slows cognitive decline by about a third.
The antibody treatment helps in the early stages of the disease.
It works in Alzheimer’s disease, not in other types of dementia, such as vascular dementia.
That is because it is designed to clear away one of the key features of Alzheimer’s disease – a substance called amyloid that builds up in the spaces between brain cells.
Please subscribe here: http://bit.ly/1rbfUog
#Dementia #Alzheimers #BBCNews
ROMA (ITALPRESS) – La Roma batte 2-1 l’Athletic Bilbao all’Olimpico nel match di andata degli ottavi di finale di Europa…
PLZEN (REPUBBLICA CECA) (ITALPRESS) – Colpaccio esterno della Lazio, che nell’andata degli ottavi di finale di Europa League vince in…
L'edizione della notte del Tg diretto da Enrico Mentana
President Putin has said that Russia will not retreat from Ukraine or “give away anything that belongs to us”. He…